Patents/Assignees

JOSLIN DIABETES CENTER, Inc.

6 patents in portfolio

US12583916utility2026
Methods to Improve Glucose Tolerance in a Subject by Administering an Antibody That Binds to Extracellular Human Metallothionein 1A (MT1A)
0 cites
US12161463utility2024
Prevention of Post-bariatric Hypoglycemia Using a Novel Glucose Prediction Algorithm and Mini-dose Stable Glucagon
0 cites
US12005039utility2024
Methods and Compositions Relating to Lipokines for Treating Metabolic Disorders
0 cites
US11885813utility2024
Methods of Diagnosing and Predicting Renal Disease
0 cites
US11866488utility2024
Compositions Comprising an Anti-metallothionein Antibody and a Pancreatic Cell Targeting Moiety
0 cites
US8343939utility2013
Methods of Modulating Angiogenesis
0 cites